Italy's CROS NT has bought out MDSL International, absorbing the U.K. company's expertise in clinical data management, statistics and other biometrics services.
CROS NT is keeping the price tag under wraps, saying only that it'll fold its new acquisition into its expanding U.K. operation, and the CRO plans to relocate its headquarters in the country to MDSL's Maidenhead facility. CEO Andrew MacGarvey, who replaced longtime chief Paolo Morelli last month, said MDSL's analytical capabilities dovetail with his company's focus on biometrics and plans for global expansion.
"We are adding a highly experienced team to the business and further diversifying our customer base--both important objectives of the CROS NT Group," MacGarvey said in a statement. "... Coming shortly after our acquisition of Stat-Tech Services in the U.S., this deal demonstrates our commitment to place expertise close to our customers and to grow to meet the increasing demand for our services."
That buyout of North Carolina's Stat-Tech gave CROS NT a presence in the U.S., and, since expanding into the U.K. in 2012, the Italian company has been working to broaden its reach around the globe.
For MDSL, hitching its platform to a larger CRO will benefit its existing clients and help CROS NT grow its roster of partners, said former CEO Edmund Otun, who will stay on after the deal closes to consult for emerging biotechs.
- read the announcement